MicroRNA-150 Deletion Reduces the Occurrence and Severity of Rheumatoid Arthritis by Inhibiting IL-17

Aihong Zhang1, Quanhui Zheng2

  • 1Department of ICU, The Affiliated Hospital of North China University of Science and Technology, Tangshan, China.

PubMed
Abstract

Insights

MicroRNA-150 deficiency alleviates rheumatoid arthritis (RA) in mice by reducing IL-17 expression in T cells and joint tissues, suggesting a therapeutic target for RA.

Area of Science:

  • Immunology
  • Epigenetics
  • Rheumatology

Background:

  • Epigenetic factors are crucial for rheumatoid arthritis (RA) pathogenesis, impacting early diagnosis and treatment.
  • MicroRNA-150 (miR-150) influences lymphocyte development and function, but its specific role in RA is not fully understood.

Purpose of the Study:

  • To investigate the role of miR-150 in rheumatoid arthritis (RA) pathogenesis.
  • To elucidate the underlying immune mechanisms involving miR-150 in RA.

Main Methods:

  • Utilized miR-150 knock-out (miR-150KO) mouse models to study RA.
  • Employed flow cytometry, immunohistochemistry, and real-time RT-PCR to analyze T cell subsets and cytokine expression.

Main Results:

  • miR-150KO mice exhibited delayed RA onset and reduced incidence compared to wild-type (WT) mice.
  • KO mice showed increased IL-4 and IFN-γ, and decreased IL-17 in T cells and joint tissues.
  • Reduced mRNA expression of TNF-α and IL-17 was observed in synovial fluid cells of KO mice.

Conclusions:

  • MiR-150 deficiency mitigates RA development and progression in mice.
  • Reduced IL-17 expression in T cells and joint tissues is a key mechanism by which miR-150 deficiency alleviates RA.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
164
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.9K